Journal of Immunology Research / 2013 / Article / Tab 1 / Research Article
TRAF1-C5 Affects Quality of Life in Patients with Primary Biliary CirrhosisTable 1 Clinical and laboratory features of 120 patients with primary biliary cirrhosis (PBC) participated in the study.
Feature PBC (
) Age (median; range) 56 (22–83) Gender (M/F) 11/109 AMA (pos/neg) 101/19
Anti-sp100 (pos/neg)27/92
Anti-gp210 (pos/neg)15/104
Cirrhosis (yes/no) (%)33/85 (28/72%) ALT (median; range) IU/L (Normal: 3–30) 90 (10–987) ALP (median; range ), IU/L (Normal: 40–120) 304 (47–2264) GGT (median; range), IU/L (Normal: 3–30) 311 (11–2608) Bilirubin (median; range), mg/dL (Normal: 0.2–1.0) 1.9 (0.2–25.1) Albumin (median; range), g/dL (Normal: 3.8–4.4) 3.9 (2.3–5.8) INR (median; range) (Normal: 0.8–1.2) 1.04 (0.8–2.3) Cholesterol (median; range ), mg/dL (
) 249 (108–1096) Triglycerides (median; range), mg/dL (
) 124 (42–448)
In 1 patient these tests were not done;
in 2 patients fibrosis status was not determined.
